Wird geladen...
Adherence to dipeptidyl peptidase‐4 inhibitor therapy among type 2 diabetes patients with employer‐sponsored health insurance in Japan
AIMS/INTRODUCTION: Dipeptidyl peptidase‐4 inhibitors (DPP‐4i) are a common first‐line treatment for type 2 diabetes in Japan. However, little is known about patients’ medication adherence, persistence and discontinuation in this setting. MATERIALS AND METHODS: This was a retrospective cohort study o...
Gespeichert in:
| Veröffentlicht in: | J Diabetes Investig |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5009136/ https://ncbi.nlm.nih.gov/pubmed/27182033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12474 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|